Design and preparation of serine–threonine protein phosphatase inhibitors based upon the nodularin and microcystin toxin structures: Part 1. Evaluation of key inhibitory features and synthesis of a rationally stripped-down nodularin macrocycle

Abstract

The natural nodularin and microcystin toxins are powerful but non-selective inhibitors of the ubiquitous and structurally related eukaryotic Ser-Thr protein phosphatases, PP1 and PP2A, enzymes that are intimately involved in controlling cellular metabolism. Both families of toxin are cyclic tri-isopeptides typified by the presence of two free carboxylic acid groups, a dehydroamino acid moiety, and a large, rigid exocyclic lipophilic side-chain. To learn how to design specific inhibitors for each enzyme, the nature of specific interactions with potential inhibitor-conferring moieties in the toxin was considered. Borohydride reduction of the dehydroalanine residue present in microcystin-LR, a potential Michael acceptor, gave two diastereoisomeric dihydromicrocystin products. Each of these displayed subnanomolar activities as inhibitors for PP2A, as for the parent compound, indicating that the dehydroamino acid residue in microcystin and, probably, in nodularin, is not essential for activity. Other conserved features appeared to be required to confer activity, hence strategies towards the synthesis of simplified non-dehydroamino acid- containing analogues of each macrocycle type were considered. In each case it was planned to elaborate the lipophilic side-chain functionality after the formation of the macrocyclic ring. In order to synthesize the precursor nodularin-type macrolactam, two peptide-bond disconnections of the ring were investigated using a model system, cyclo-[β-Ala-(R)-Glu-α- OMe-γ-Sar-(R)-Asp-α-OMe- β-(S)-Phe-], one bond disconnecting between the sarcosine carboxy group and the (2R)-Asp N-atom and the other disconnecting between the (2R)-Asp β-carboxy group and the (2S)-Phe N-atom. Preparation of the linear precursors was achieved using solution-phase chemistry without incident. Macrolactamisation via the displacement of the β-pentafluorophenyl ester of the (2R)-Asp α-methyl ester residue by the free amino group of the (2S)-phenylalanine residue proceeded in excellent yield (89%), but the alternative strategy failed. Application of the successful macrolactamisation strategy to other nodularin macrocycles and to the construction of the microcystin-type macrocycle is described in the following article.

References

1. T. Hunter, Cell, 1995, 80, 225.
2. P. Cohen, Annu. Rev. Biochem., 1989, 58, 453; P. T. W. Cohen, N. D. Brewis, V. Hughes and D. Mann, FEBS Lett., 1990, 268, 355.
3. S. Shenolikar and A. C. Nairn, in Advances in Second Messenger and Phosphoprotein Research, ed. P. Greengard and G. A. Robinson, Raven Press, Ltd., New York, 1991, vol. 23, pp. 1–121.
4. M. Bollen and W. Stalmans, Crit. Rev. Biochem. Mol. Biol., 1992, 27, 227.
5. A. A. Depaoli-Roach, I.-K. Park, V. Cerovsky, C. Csortos, S. D. Durbin, M. J. Kuntz, A. Sitikov, P. M. Tang, A. Verin and S. Zolnierowicz, Adv. Enzyme Regul., 1994, 34, 199.
6. M. J. Hubbard and P. Cohen, Trends Biochem. Sci., 1993, 18, 172.
7. B. McCright and D. Virshup, J. Biol. Chem., 1995, 270, 26 123.
8. M. C. Faux and J. D. Scott, Trends Biochem. Sci., 1996, 21, 312.
9. D. P. Botes, A. A. Tuinman, P. L. Wessels, C. C. Wiljoen, H. Kruger, D. H. Williams, S. Santikarn, R. J. Smith and S. J. Hammond, J. Chem. Soc., Perkin Trans. 1, 1984, 2311.
10. D. P. Botes, P. L. Wessels, H. Kruger, M. T. C. Runnegar, S. Santikarn, R. J. Smith, J. C. J. Barna and D. H. Williams, J. Chem. Soc., Perkin Trans. 1, 1985, 2747.
11. W. W. Carmichael, in Natural Toxins; Characterisation, Pharmacology and Therapeutics, Pergamon Press, London, 1988, pp. 3–16.
12. W. W. Carmichael, V. R. Beasley, D. L. Bunner, J. N. Eloff, I. R. Falconer, P. Gorham, K.-I. Harada, M.-J. Yu, T. Krishnamurthy, R. E. Moore, K. L. Rinehart, M. T. C. Runnegar, O. M. Skulberg and M. Watanabe, Toxicon, 1988, 26, 971.
13. K. L. Rinehart, K.-I. Harada, M. Namikoshi, C. Chen, C. A. Harvis, M. H. G. Munro, J. W. Blunt, P. E. Mulligan, V. R. Beasley, A. M. Dahlem and W. W. Carmichael, J. Am. Chem. Soc., 1988, 110, 8557.
14. K. Sivonen, K. Konen, W. W. Carmichael, A. M. Dahlem, K. L. Rinehart, J. Kiviranta and S. Niemela, Appl. Environ. Microbiol., 1989, 55, 1990.
15. M. Namikoshi, B. W. Choi, R. Sakai, K. L. Rinehart, W. W. Carmichael, W. R. Evans, P. Cruz, M. H. G. Munro and J. W. Blunt, J. Org. Chem., 1994, 59, 2349.
16. W. W. Carmichael, J. Appl. Bacteriol., 1992, 72, 445.
17. R. E. Honkanen, J. Zwiller, S. L. Daily, B. S. Khatra, M. Dukelow and A. L. Boynton, J. Biol. Chem., 1991, 266, 6614.
18. I. R. Falconer, A. M. Beresford and M. T. C. Runnegar, Med. J. Aust., 1983, 1, 511.
19. S.-Z. Yu, in Primary Liver Cancer, eds. Z. Y. Tang, M. C. Wu and S. S. Xia, Springer-Verlag, Berlin, 1989, pp. 30–37.
20. M. T. C. Runnegar, I. R. Falconer and J. Silver, Naunyn–Schmiedeberg's Arch. Pharmacol., 1981, 317, 268.
21. M. T. C. Runnegar, R. G. Gerdes and I. R. Falconer, Toxicon, 1991, 29, 43.
22. C. F. B. Holmes and M. P. Boland, Curr. Opin. Struct. Biol., 1993, 3, 934.
23. J. Goldberg, H.-B. Huang, Y.-G. Kwon, P. Greengard, A. C. Nairn and J. Kuriyan, Nature, 1995, 376, 745.
24. M.-P. Egloff, P. T. W. Cohen, P. Reinemer and D. Barford, J. Mol. Biol., 1995, 254, 942.
25. D. Gani and J. Wilkie, Metal Ions in the Mechanism of Enzyme Catalysed Phosphate Monoester Hydrolyses in Structure and Bonding, ed. H. A. Hill, P. J. Sadler and A. J. Thomson, Springer-Verlag, Berlin, Heidelberg, 1997, 89, pp. 133–175.
26. E. D. de Silva, D. E. Williams, R. J. Andersen, H. Klix, C. F. B. Holmes and T. Allen, Tetrahedron Lett., 1992, 33, 1561.
27. S. Rudolph-Bohner, D. F. Mierke and L. Moroder, FEBS Lett., 1994, 349, 319; D. F. Mierke, S. Rudolph-Bohner, G. Muller and L. Moroder, Biopolymers, 1995, 36, 811.
28. A. Annila, J. Lehtimaki, K. Mattila, J. E. Eriksson, K. Sivonen, T. T. Rantala and T. Drakenberg, J. Biol. Chem., 1996, 271, 16 695.
29. M. Namikoshi, K. L. Rinehart, R. Sakai, R. R. Stotts, A. M. Dahlem, V. R. Beasley, W. W. Carmichael and W. R. Evans, J. Org. Chem., 1992, 57, 866.
30. K. L. Rinehart, M. Namikoshi and B. W. Choi, J. Appl. Phycology, 1994, 6, 159.
31. R. Nishiwaki-Matsushima, S. Nishiwaki, T. Ohta, S. Yoshizawa, M. Suganuma, K.-I. Harada, M. F. Watanabe and H. Fujiki, Jpn. J. Cancer Res., 1991, 82, 993.
32. K.-I. Harada, K. Ogawa, K. Matsuura, H. Murata, M. Suzuki, M. F. Watanabe, Y. Itezono and N. Nakayama, Chem. Res. Toxicol., 1990, 3, 473.
33. M. Namikoshi, K. L. Rinehart, V. R. Beasley and W. W. Carmichael, Tetrahedron Lett., 1989, 30, 4349.
34. M. Namikoshi, K. L. Rinehart, R. Sakai, K. Sivonen and W. W. Carmichael, J. Org. Chem., 1990, 55, 6135.
35. C. Taylor, R. J. Quinn, M. Suganuma and H. Fujiki, Bioorg. Med. Chem. Lett., 1996, 6, 2113.
36. R. J. Valentekovich and S. L. Schreiber, J. Am. Chem. Soc., 1995, 117, 9069.
37. P. Hormozdiari and D. Gani, Tetrahedron Lett., 1996, 37, 8227.
38. M. Namikoshi, B. W. Choi, F. Sun, K. L. Rinehart, W. R. Evans and W. W. Carmichael, Chem. Res. Toxicol., 1993, 6, 151.
39. A. P. Mehrotra, Ph.D. Thesis, University of St. Andrews, 1995.
40. R. W. MacKintosh, K. N. Dalby, D. G. Campbell, P. Cohen and C. MacKintosh, FEBS Lett., 1995, 371, 236.
41. G. Moorhead, R. W. MacKintosh, N. Morrice, T. Gallagher and C. MacKintosh, FEBS Lett., 1994, 356, 46.
42. M. S. Gulzar, K. B. Morris and D. Gani, J. Chem. Soc., Chem. Commun., 1995, 1061.
43. M. Akhtar, N. P. Botting, M. A. Cohen and D. Gani, Tetrahedron, 1987, 43, 5899.
44. J. M. Scholtz and P. A. Bartlett, Synthesis, 1989, 542.
45. S. F. Brady, R. M. Freidinger, W. J. Paleveda, C. D. Colton, C. F. Homnick, W. L. Whitter, P. Curley, R. F. Nutt and D. F. Veber, J. Org. Chem., 1987, 52, 764.
46. P. Wipf and H. Kim, J. Org. Chem., 1993, 58, 5592.
47. K. L. Webster, A. P. Mehrotra, A. B. Maude, D. Gani and T. J. Rutherford, parts 3 and 4 in this series, in preparationAlso see K. L. Webster, T. J. Rutherford and D. Gani, Tetrahedron Lett., 1997, 38, 5713.
48. A. B. Maude, A. P. Mehrotra and D. Gani, following paper.
49. T. K. Chakraborty and S. P. Joshi, Tetrahedron Lett., 1990, 31, 2043; M. F. Beatty, C. Jennings-White and M. A. Avery, J. Chem. Soc., Perkin Trans. 1, 1992, 1637; H. Y. Kim and P. L. Toogood, Tetrahedron Lett., 1996, 37, 2349; F. D'Aniello, A. Mann and M. Taddei, J. Org. Chem., 1996, 61, 4870; N. Sin and J. Kallmerten, Tetrahedron Lett., 1996, 37, 5645; F. D'Aniello, A. Mann, A. Schoenfelder and M. Taddei, Tetrahedron, 1997, 53, 1447.
50. J. M. Humphrey, J. B. Aggen and A. R. Chamberlain, J. Am. Chem. Soc., 1996, 118, 11 759.
51. D. D. Perrin, W. L. F. Armarego and D. R. Perrin, in Purification of Laboratory Chemicals, Pergamon Press, Oxford, 1980.
52. C. MacKintosh, K. A. Beattie, S. Klumpp, P. Cohen and G. A. Codd, FEBS Lett., 1990, 264, 187.
53. E. Kato, K. Yamamoto, Y. Kawashima, T. Watanabe, M. Oya, T. Iso and J. Iwao, Chem. Pharm. Bull., 1985, 33, 4836.
54. S. Kim, J. I. Lee and Y. C. Kim, J. Org. Chem., 1985, 50, 560.
55. E. Wünsch, in Methoden der Organischen Chemi: Synthese Von Peptiden I, ed. M. Deffner, K.-H. Deimer, E. Jaeger, P. Stelzel, P. Thamm, G. Wendlberger and E. Wünsch, Georg Thieme Verlag, Stuttgart, 1974, p. 685.